Mechanism of hard-nanomaterial clearance by the liver

Nature Materials

Volumn 15, Issue 11, 2016, Pages 1212-1221

  Tsoi, Kim M ^a,b   Macparland, Sonya A ^b   Ma, Xue Zhong ^c   Spetzler, Vinzent N ^c   Echeverri, Juan ^c   Ouyang, Ben ^a   Fadel, Saleh M ^b   Sykes, Edward A ^a   Goldaracena, Nicolas ^c   Kaths, Johann M ^c   Conneely, John B ^c   Alman, Benjamin A ^d   Selzner, Markus ^c   Ostrowski, Mario A ^b   Adeyi, Oyedele A ^e   Zilman, Anton ^a,f   McGilvray, Ian D ^c   Chan, Warren C W ^a,b,f  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e TORONTO GENERAL HOSPITAL   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; CELLS; CYTOLOGY; ENDOTHELIAL CELLS; LIVER; MACROPHAGES; SEMICONDUCTOR QUANTUM DOTS; SURFACE CHEMISTRY;

BIOLOGICAL BARRIER; BLOOD FLOW DYNAMICS; CELLULAR PHENOTYPES; DISEASED TISSUES; HEPATIC CELLS; KUPFFER CELLS; LIVER SINUSOIDAL ENDOTHELIAL CELLS; MICRO ARCHITECTURES;

NANOSTRUCTURED MATERIALS;

NANOMATERIAL;

CYTOLOGY; HARDNESS; LIVER; METABOLISM; PHENOTYPE; SURFACE PROPERTY;

HARDNESS; LIVER; NANOSTRUCTURES; PHENOTYPE; SURFACE PROPERTIES;

EID: 84982136636     PISSN: 14761122     EISSN: 14764660     Source Type: Journal    
DOI: 10.1038/nmat4718     Document Type: Article

References (45)

1. Kim, B. Y., Rutka, J. T. &Chan, W. C. Nanomedicine. N. Engl. J. Med. 363, 2434-2443 (2010).
2. Veiseh, O., Tang, B. C., Whitehead, K. A., Anderson, D. G. &Langer, R. Managing diabetes with nanomedicine: challenges and opportunities. Nat. Rev. Drug. Discov. 14, 45-57 (2014).
3. Mulder, W. J. M., Jaer, F. A., Fayad, Z. A. &Nahrendorf, M. Imaging and nanomedicine in inflammatory atherosclerosis. Sci. Transl. Med. 6, 239sr1 (2014).
4. Nasongkla, N. et al. Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Lett. 6, 2427-2430 (2006).
5. Jaiswal, J. K., Mattoussi, H., Mauro, J. M. &Simon, S. M. Long-term multiple color imaging of live cells using quantum dot bioconjugates. Nat. Biotechnol. 21, 47-51 (2002).
6. Dhar, S., Daniel, W. L., Giljohann, D. A., Mirkin, C. A. &Lippard, S. J. Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum(IV) warheads. J. Am. Chem. Soc. 131, 14652-14653 (2009).
7. Kam, N. W. S., O'Connell, M., Wisdom, J. A. &Dai, H. Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. Proc. Natl Acad. Sci. USA 102, 11600-11605 (2005).
8. Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S. &Audet, J. Analysis of nanoparticle delivery to tumours. Nat. Rev. Mater. 1, 16014 (2016).
9. Zhang, C. et al. Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel. Biomaterials 29, 1233-1241 (2008).
10. Fonge, H., Huang, H., Scollard, D., Reilly, R. M. &Allen, C. Influence of formulation variables on the biodistribution of multifunctional block copolymer micelles. J. Control. Release 157, 366-374 (2012).
11. Ye, L. et al. A pilot study in non-human primates shows no adverse response to intravenous injection of quantum dots. Nat. Nanotech. 7, 453-458 (2012).
12. Fischer, H. C., Liu, L., Pang, K. S. &Chan, W. C. W. Pharmacokinetics of nanoscale quantum dots: in vivo distribution, sequestration, and clearance in the rat. Adv. Funct. Mater. 16, 1299-1305 (2006).
13. Semmler-Behnke, M. et al. Biodistribution of 1. 4-and 18-nm gold particles in rats. Small 4, 2108-2111 (2008).
14. De Jong, W. H. et al. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 29, 1912-1919 (2008).
15. Liu, Z. et al. In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. Nat. Nanotech. 2, 47-52 (2006).
16. Yang, S. T. et al. Biodistribution of pristine single-walled carbon nanotubes in vivo. J. Phys. Chem. C 111, 17761-17764 (2007).
17. Hauck, T. S., Anderson, R. E., Fischer, H. C., Newbigging, S. &Chan, W. C. W. In vivo quantum-dot toxicity assessment. Small 6, 138-144 (2010).
18. Kuwahira, I., Gonzalez, N. C., Heisler, N. &Piiper, J. Changes in regional blood flow distribution and oxygen supply during hypoxia in conscious rats. J. Appl. Physiol. 74, 211-214 (1993).
19. Fournier, L. S. et al. Early modifications of hepatic perfusion measured by functional CT in a rat model of hepatocellular carcinoma using a blood pool contrast agent. Eur. Radiol. 14, 2125-2133 (2004).
20. Miyazaki, S. et al. Investigation on the optimal position for the quantification of hepatic perfusion by use of dynamic contrast-enhanced computed tomography in rats. Radiol. Phys. Technol. 2, 183-188 (2009).
21. Menger, M. D., Marzi, I. &Messmer, K. In vivo fluorescence microscopy for quantitative analysis of the hepatic microcirculation in hamsters and rats. Eur. Surg. Res. 23, 158-169 (1991).
22. MacPhee, P. J., Schmidt, E. E. &Groom, A. C. Intermittence of blood flow in liver sinusoids, studied by high-resolution in vivo microscopy. Am. J. Physiol. Gastrointest. Liver Physiol. 269, G692-G698 (1995).
23. Ingham, D. B. Diffiusion of aerosols from a stream flowing through a cylindrical tube. J. Aerosol. Sci. 6, 125-132 (1975).
24. Davies, C. N. Diffiusion and sedimentation of aerosol particles from Poiseuille flow in pipes. J. Aerosol. Sci. 4, 317-328 (1973).
25. Dobrovolskaia, M. A. &McNeil, S. E. Immunological properties of engineered nanomaterials. Nat. Nanotech. 2, 469-478 (2007).
26. Lunov, O. et al. Diffierential uptake of functionalized polystyrene nanoparticles by human macrophages and a monocytic cell line. ACS Nano 5, 1657-1669 (2011).
27. Wang, H., Wu, L. &Reinhard, B. M. Scavenger receptor mediated endocytosis of silver nanoparticles into J774A. 1 macrophages is heterogeneous. ACS Nano 6, 7122-7132 (2012).
28. Sykes, E. A., Chen, J., Zheng, G. &Chan, W. C. W. Investigating the impact of nanoparticle size on active and passive tumor targeting efficiency. ACS Nano 8, 5696-5706 (2014).
29. Perrault, S. D., Walkey, C., Jennings, T., Fischer, H. C. &Chan, W. C. W. Mediating tumor targeting efficiency of nanoparticles through design. Nano Lett. 9, 1909-1915 (2009).
30. Cho, W.-S. et al. Size-dependent tissue kinetics of PEG-coated gold nanoparticles. Toxicol. Appl. Pharmacol. 245, 116-123 (2010).
31. Chithrani, B. D. &Chan, W. C. W. Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of Diffierent sizes and shapes. Nano Lett. 7, 1542-1550 (2007).
32. Gao, H. J., Shi, W. D. &Freund, L. B. Mechanics of receptor-mediated endocytosis. Proc. Natl Acad. Sci. USA 102, 9469-9474 (2005).
33. Cormode, D. P. et al. A versatile and tunable coating strategy allows control of nanocrystal delivery to cell types in the liver. Bioconjug. Chem. 22, 353-361 (2011).
34. Cheng, S.-H. et al. Visualizing dynamics of sub-hepatic distribution of nanoparticles using intravital multiphoton fluorescence microscopy. ACS Nano 6, 4122-4131 (2012).
35. Akinc, A. et al. Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms. Mol. Ther. 18, 1357-1364 (2010).
36. Sadauskas, E. et al. Kupfier cells are central in the removal of nanoparticles from the organism. Part. Fibre Toxicol. 4, 10-17 (2007).
37. Bartneck, M. et al. Peptide-functionalized gold nanorods increase liver injury in hepatitis. ACS Nano 6, 8767-8777 (2012).
38. Nakashima, M. et al. Pivotal advance: characterization of mouse liver phagocytic B cells in innate immunity. J. Leukoc. Biol. 91, 537-546 (2012).
39. Stock, R. J., Cilento, E. V., Reilly, F. D. &McCuskey, R. S. A compartmental analysis of the splenic circulation in rat. Am. J. Physiol. Heart Circ. Physiol. 245, H17-H21 (1983).
40. Chadburn, A. The spleen: anatomy and anatomical function. Semin. Hematol. 37, 13-21 (2000).
41. Delp, M. D., Evans, M. V. &Duan, C. effiects of aging on cardiac output, regional blood flow, and body composition in Fischer-344 rats. J. Appl. Physiol. 85, 1813-1822 (1998).
42. Walkey, C. D., Olsen, J. B., Guo, H., Emili, A. &Chan, W. C. W. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J. Am. Chem. Soc. 134, 2139-2147 (2012).
43. Jones, S. W. et al. Nanoparticle clearance is governed by Th1/Th2 immunity and strain background. J. Clin. Invest. 123, 3061-3073 (2013).
44. Koo, A., Liang, I. Y. &Cheng, K. K. Hepatic sinusoidal responses to intraportal injections of phenylephrine and isoprenaline in the rat. Clin. Exp. Pharmacol. Physiol. 3, 391-395 (1976).
45. Hagemann, T. et al. Re-educating' tumor-associated macrophages by targeting NF-B. J. Exp. Med. 205, 1261-1268 (2008).